#SGIMNorthwest Regional Meeting Attendees: After a short transition break, we’ll move into Concurrent Clinical Updates featuring inpatient and outpatient perspectives from regional experts from 8:50–9:35 am in the Alpine and Bonneville rooms. #SGIM #SGIMNorthwest #ClinicalUpdates #HospitalMedicine

🩸More insights on emerging therapies & future directions in Inherited Bone Marrow Failure Syndromes

#AndrogenTherapy #Danazol #Telomeres #BoneMarrowFailure #IBMFS #Eltrombopag #ClonalEvolution #CD117 #Hematopoiesis #StemCellTherapy #Hematology #ClinicalUpdates #MedEd #HEMEHUB

🩸 Mark your calendars! Join us for an expert-led, in-person program on practical #hematology insights, part of our 2026 Hematology Summit series with Texas Oncology.

Additional program details will be announced soon.

👉 Learn more: hemehub.org/hybrid-events

#HemeHub #HybridEvents #ClinicalUpdates

🩸 Additional facts on diagnostic nuances and clinical presentation in Inherited Bone Marrow Failure Syndromes

#Hematology #BoneMarrowFailure #IBMFS #InheritedDisorders #RareHematology #MedEd #ClinicalUpdates #HemeHub

🩸 Additional facts on diagnostic nuances and clinical presentation in Inherited Bone Marrow Failure Syndromes

#Hematology #BoneMarrowFailure #IBMFS #InheritedDisorders #RareHematology #MedEd #ClinicalUpdates #HemeHub

🩸🌍 HemeHub launches its 2026 educational programming this January, offering expert-led, case-based sessions and timely clinical updates throughout the year.

🔗Visit hemehub.org today to learn more!

#HemeHub #Hematology #BoneMarrowFailure #IBMFS #MedEd #ClinicalUpdates #RareHematology #HEMEHUB

We are excited to share new additions to the HemeHub platform, including hybrid events that translate emerging evidence into clinical practice.

👉 Explore our hybrid events and the 2026 symposium:
hemehub.org/hybrid-events

#Hematology #HemeHub #HybridEvents #ClinicalUpdates #PatientCare #HemeOnc

When the Nurse Sends You the New Plan of Care But You’ve Already Scheduled?

staffingly.com/scheduling-c...

#HomeCare #CareScheduling #PatientCare #ClinicalUpdates #RealTimeTracking #Teamwork #Caregiving #Staffingly #Healthcare

Does Combination Therapy Improve Albuminuria? Finerenone plus empagliflozin reduced urinary albumin-to-creatinine ratio by 29% to 32% more than either drug alone in patients with chronic kidney disease and type 2 diabetes.

Exploring whether combination therapy can improve albuminuria in patients with type 2 diabetes and chronic kidney disease. Insights may inform treatment strategies in #InternalMedicine and #Nephrology.
#ClinicalUpdates #KidneyHealth